Comparative effectiveness of upadacitinib versus ustekinumab in patients with moderately to severely active Crohn's disease: a matching-adjusted indirect comparison

被引：0
|
作者：
Ma, C. [1 ]
Dubinsky, M. C. [2 ]
Axelrad, J. [3 ]
Anyanwu, S. [4 ]
Tran, J. [5 ,6 ]
Lacerda, A. [4 ]
Joshi, N. [4 ]
Griffith, J. [4 ]
机构：
[1] Univ Calgary, Dept Med, Inflammatory Bowel Dis Clin, Calgary, AB, Canada
[2] Icahn Sch Med Mt Sinai, Div Pediat Gastroenterol & Nutr, New York, NY USA
[3] NYU Grossman Sch Med, Div Gastroenterol, Dept Med, New York, NY USA
[4] AbbVie Inc, Chicago, IL USA
[5] AbbVie Inc, Seattle, WA USA
[6] Univ Washington, Comparat Hlth Outcomes Policy & Econ Inst, Seattle, WA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1040
引用
收藏
页码：I1866 / I1867
页数：2
相关论文
共 50 条
  • [31] Corticosteroid-Sparing Effect of Upadacitinib in Patients With Moderately-to-Severely Active Crohn's Disease
    Dubinsky, Marla C.
    D'Haens, Geert
    Dewit, Olivier
    Juillerat, Pascal
    Panaccione, Remo
    Fujii, Toshimitsu
    Lacerda, Ana P.
    Dubcenco, Elena
    Anyanwu, Samuel I.
    Doshi, Chirag
    Liu, Jianzhong
    Garrison, Andrew
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S886 - S887
  • [32] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
    Dubinsky, Marla C.
    D'Haens, Geert
    Dewit, Olivier
    Juillerat, Pascal
    Panaccione, Remo
    Fujii, Toshimitsu
    Lacerda, Ana P.
    Dubcenco, Elena
    Anyanwu, Samuel
    Doshi, Chirag
    Mallick, Madhuja
    Garrison, Andrew
    Liu, John
    Loftus, Edward V., Jr.
    SWISS MEDICAL WEEKLY, 2023, 153 : 9S - 10S
  • [33] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
    Dubinsky, M. C.
    D'Haens, G.
    Dewit, O.
    Juillerat, P.
    Panaccione, R.
    Fujii, T.
    Lacerda, A. P.
    Dubcenco, E.
    Anyanwu, S.
    Doshi, C.
    Mallick, M.
    Garrison, A.
    Liu, J.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I104 - I106
  • [34] MATCHING-ADJUSTED INDIRECT COMPARISON ON CLINICAL REMISSION FOR MIRIKIZUMAB AND RISANKIZUMAB MAINTENANCE IN THE TREATMENT OF ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS
    Siegel, Corey
    Hoque, Sami
    Abreu, Maria
    Zhu, Baojin
    Escobar, Rodrigo
    Redondo, Isabel
    Owen, Charles
    Yang, Chao
    Keohane, Anthony
    Dignass, Axel
    INFLAMMATORY BOWEL DISEASES, 2025, 31 : S10 - S11
  • [35] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN BIO-NAIVE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE IN CANADA
    Bessissow, Talat
    Narula, Neeraj
    Ma, Christopher
    In, Tracy S.
    Eberg, Maria
    Karra, Kinda
    Belgnaoui, Mehdi
    Jairath, Vipul
    GASTROENTEROLOGY, 2022, 162 (07) : S811 - S811
  • [36] COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED WITH USTEKINUMAB AS TREATMENT FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE IN THE UNITED STATES
    Zouraq, Azzabi, I
    Wilson, M.
    Hather, G.
    Curtis, R.
    Luo, M.
    Khalid, J. M.
    Minda, K.
    VALUE IN HEALTH, 2017, 20 (05) : A183 - A183
  • [37] Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
    Bhak, Rachel H.
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher W.
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (11) : 1913 - 1923
  • [38] Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Previously Treated with Eculizumab: A Matching-Adjusted Indirect Comparison
    Bhak, Rachel Y.
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    BLOOD, 2020, 136
  • [39] Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
    Bhak, Rachel
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 190 - 190
  • [40] Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison
    Maksymowych, Walter P.
    Strand, Vibeke
    Nash, Peter
    Yazici, Yusuf
    Thom, Howard
    Hunger, Matthias
    Kalyvas, Chrysostomos
    Gandhi, Kunal K.
    Porter, Brian
    Jugl, Steffen M.
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (04) : 216 - +
12345